tradingkey.logo
搜尋

Clearpoint Neuro Inc

CLPT
添加自選
18.720USD
0.0000.00%
收盤 07/02, 13:00美東報價延遲15分鐘
561.35M總市值
虧損本益比TTM

Clearpoint Neuro Inc

18.720
0.0000.00%
查看詳細走勢圖
TradingKey 图表
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

0.00%

5天

+1.30%

1月

+30.73%

6月

+33.43%

今年開始到現在

+36.84%

1年

+60.00%

關鍵數據
18.650今開
19.410最高
599.06K成交量
虧損本益比TTM
虧損本益比動
--股利TTM
2.00%換手率
18.720昨收
18.030最低
8.91M成交額
虧損本益比靜
29.79市淨率
0.00%股息率 TTM
-47.08%ROA
30.10052週最高
1.12量比
-18.91M淨利潤
29.99M總股本
-1.0079每股盈餘TTM
1.30Beta
-149.72%ROE
8.27052週最低
7.37%振幅
63.95%毛利率
561.35M總市值
6.43回報/風險
4.78%風險率

TradingKey Clearpoint Neuro Inc股票評分

單位: USD 更新時間: 2026-07-02

操作建議

Clearpoint Neuro Inc當前公司基本面數據相對健康,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名61/204位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為28.33。中期看,股價處於上升通道。近一個月,市場表現很強,技術面和基本面綜合得分較高,很強的走勢得到基本面和技術面的印證。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Clearpoint Neuro Inc評分

相關信息

行業排名
61 / 204
全市場排名
153 / 4565
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
看好

Clearpoint Neuro Inc亮點

亮點風險
ClearPoint Neuro, Inc. is a device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. The Company provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. Its flagship product is the ClearPoint Neuro Navigation System. The Company is engaged with healthcare and research centers in North America, Europe, Asia, and South America. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. Its ClearPoint Prism Neuro Laser Therapy System is indicated for use to necrotize or coagulate soft tissue through interstitial irradiation or thermal therapy for neuro applications under 3.0T magnetic resonance imaging (MRI) guidance. The Company also provides solutions for direct CNS delivery of therapeutics in preclinical studies and clinical trials worldwide.
業績高增長
公司營業收入穩步增長,連續3年增長54.34%
業績增長期
公司處於發展階段,最新年度總收入36.97M美元
利潤高增長
公司淨利潤處於行業前列,最新年度總收入36.97M美元
估值低估
公司最新PE估值-18.57,處於3年歷史低位
機構加倉
最新機構持股15.83M股,環比增加10.52%
活躍度增加
近期活躍度增加,過去20天平均換手率1.01

分析師目標

基於 3 分析師
買入
評級
28.333
目標均價
+51.35%
漲幅空間

Clearpoint Neuro Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Clearpoint Neuro Inc簡介

ClearPoint Neuro, Inc. is a device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. The Company provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. Its flagship product is the ClearPoint Neuro Navigation System. The Company is engaged with healthcare and research centers in North America, Europe, Asia, and South America. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. Its ClearPoint Prism Neuro Laser Therapy System is indicated for use to necrotize or coagulate soft tissue through interstitial irradiation or thermal therapy for neuro applications under 3.0T magnetic resonance imaging (MRI) guidance. The Company also provides solutions for direct CNS delivery of therapeutics in preclinical studies and clinical trials worldwide.
公司代碼CLPT
公司Clearpoint Neuro Inc
CEOBurnett (Joseph Michael)
網址https://www.clearpointneuro.com/

常見問題

Clearpoint Neuro Inc(CLPT)的當前股價是多少?

Clearpoint Neuro Inc(CLPT)的當前股價是 18.72。

Clearpoint Neuro Inc 的股票代碼是什麼?

Clearpoint Neuro Inc的股票代碼是CLPT。

Clearpoint Neuro Inc股票的52週最高點是多少?

Clearpoint Neuro Inc股票的52週最高點是30.10。

Clearpoint Neuro Inc股票的52週最低點是多少?

Clearpoint Neuro Inc股票的52週最低點是8.27。

Clearpoint Neuro Inc的市值是多少?

Clearpoint Neuro Inc的市值是549.78M。

現在Clearpoint Neuro Inc(CLPT)的股票是買入、持有還是賣出?

根據分析師評級,Clearpoint Neuro Inc(CLPT)的總體評級為買入,目標價格為28.33。

Clearpoint Neuro Inc(CLPT)股票的每股收益(EPS TTM)是多少

Clearpoint Neuro Inc(CLPT)股票的每股收益(EPS TTM)是-0.90。